Pulmonary Function After Hyperbaric Oxygen Therapy

Status Completed

Clinical Trial Summary

Patients receiving hyperbaric oxygen therapy (HBOT) for any indication at the Hyperbaric Medicine Unit (University Health Network, Toronto, ON, Canada) from 2016-2021 were recruited to this prospective cohort study. While receiving HBOT (at 2.0-2.4 ATA, with 1-3 "air breaks", with specific treatment details determined on a case-by-case basis and directed by the clinical team), enrolled patients underwent pulmonary function testing prior to HBOT treatment and serially after each 20 completed treatment cycles.

Clinical Trial Description

Patients receiving hyperbaric oxygen therapy (HBOT) at the Hyperbaric Medicine Unit (University Health Network, Toronto, ON, Canada) from 2016-2021 were recruited with informed consent to this prospective cohort study. All included patients underwent HBOT in one of three monoplace chambers (Sechrist 3600H and Sechrist 4100H, Sechrist Industries Inc., Anaheim, CA, USA; PAH-S1-3200, Pan-America Hyperbarics Inc., Plano, TX, USA) or via a plastic hood in a multiplace chamber (Hyperbaric System, Fink Engineering PTY-LTD, Warana, Australia). HBOT was performed with 100% oxygen at 2.0-2.4 ATA, with 1-3 "air breaks", typically at 5 sessions per week, with limited variation depending on the treatment indication and patient/clinician decision. Study participants completed pulmonary function testing (PFTs) at several intervals during their HBOT treatment: prior to the first HBOT session, and serially after every 20 subsequent treatments. PFTs were performed using a KoKo Trek USB Spirometer software and pneumotachometer (KoKo, USA), with the assistance of a trained technician and in accordance with industry norms. Retrospectively, PFT data was collected from all enrolled patients' electronic and paper medical charts. This data included anonymized patient demographics, as well as percentage of predicted forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and forced mid-expiratory flow rates (FEF25-75). PFT values underwent statistical analysis to identify potential effects of HBOT on pulmonary function. ;

Study Design

Related Conditions & MeSH terms

Oxygen Toxicity

Clinical Trial Details

NCT number	NCT05088772
Study type	Observational
Source	University of Toronto
Contact
Status	Completed
Phase
Start date	February 2016
Completion date	October 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05508308` - Automated Versus Manual Control Of Oxygen For Preterm Infants On Continuous Positive Airway Pressure In Nigeria	N/A
Enrolling by invitation	`NCT05831228` - Effects of Pre-dive Ketone Food Products on Latency to CNS Oxygen Toxicity (Aim 2)	N/A
Recruiting	`NCT04136717` - Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery	N/A
Active, not recruiting	`NCT04133740` - Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study	Phase 4
Completed	`NCT03653325` - ORI to Reduce Hyperoxia After Out Hospital Cardiac Arrest	N/A
Recruiting	`NCT05761756` - Oxygen Toxicity: Mechanisms in Humans	N/A
Completed	`NCT02698020` - Optimized Oxygen Delivery During General Anesthesia in Newborn Infants	N/A
Recruiting	`NCT05590130` - Comparison of Two Oxygenation Targets With Two Different Oximeters - Impact on Oxygen Flow Rates and Oxygenation	N/A
Terminated	`NCT03665259` - Lower Inspiratory Oxygen Fraction for Preoxygenation	N/A
Completed	`NCT03114176` - Effects of Ketogenic Diet in Divers Breathing Enriched Air Nitrox	N/A
Enrolling by invitation	`NCT05801120` - Effects of Pre-dive Ketone Food Products on Latency to CNS Oxygen Toxicity (Aim 1)	N/A
Not yet recruiting	`NCT05737407` - Lung Ultrasound Guided Choice of Best Positive End-Expiratory Pressure in Neonatal Anesthesia	N/A
Recruiting	`NCT04802629` - Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.
Completed	`NCT03174002` - Handling Oxygenation Targets in the Intensive Care Unit	Phase 4
Recruiting	`NCT03937622` - Northern Survey on Therapeutic Oxygen Prescription
Completed	`NCT03453294` - Effect of THRIVE During Apneic Oxygenation in General Anesthesia on Biomarkers	N/A
Completed	`NCT03754985` - Hyperbaric Oxygen Therapy Effects on Pulmonary Functions
Completed	`NCT03789396` - Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients
Completed	`NCT03625700` - Supplementary Oxygen in Surgical and Medical Wards Evaluated by 30-day Mortality
Recruiting	`NCT05414370` - Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model	N/A